CVS Health to hold first quarter 2024 earnings conference call
WOONSOCKET, R.I., April 1, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, May 1st, 2024, at 8:00 a.m. ET to discuss first quarter 2024 financial results.
An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.
About CVS Health CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues ? including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health ? whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system ? and their personal health care ? by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced first quarter 2024 financial results and highlighted recent corporate updates....
The judgment in Bennett, et. al v. Providence Health & Services, was entered in King County Superior Court yesterday, the culmination of a two-week trial which took place late last month. Providence is ordered to pay more than 33,000 of its hourly...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and...
Dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced its financial and operating results for the first quarter ended March 31, 2024. All...
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it has been selected as the winner of the "Best Overall Mental Health Solution" award in the eighth annual MedTech...
REGENXBIO Inc. today announced it will participate in the following upcoming investor conferences:
BofA Securities Health Care Conference 2024Fireside Chat: Wednesday, May 15, 2024 at 2:20 p.m. ETLocation: Las Vegas, NV
Stifel 2024 Tailoring Genes...
